Manulife (Manufacturers Life Insurance)’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $171K | Buy |
15,099
+1,862
| +14% | +$21.1K | ﹤0.01% | 2616 |
|
2025
Q1 | $88K | Sell |
13,237
-67
| -0.5% | -$446 | ﹤0.01% | 2728 |
|
2024
Q4 | $147K | Sell |
13,304
-314
| -2% | -$3.46K | ﹤0.01% | 2726 |
|
2024
Q3 | $167K | Sell |
13,618
-346
| -2% | -$4.25K | ﹤0.01% | 2727 |
|
2024
Q2 | $189K | Buy |
13,964
+1,994
| +17% | +$26.9K | ﹤0.01% | 2627 |
|
2024
Q1 | $162K | Buy |
11,970
+54
| +0.5% | +$729 | ﹤0.01% | 2669 |
|
2023
Q4 | $62.7K | Hold |
11,916
| – | – | ﹤0.01% | 2903 |
|
2023
Q3 | $46.9K | Sell |
11,916
-35,355
| -75% | -$139K | ﹤0.01% | 2944 |
|
2023
Q2 | $502K | Buy |
47,271
+2,119
| +5% | +$22.5K | ﹤0.01% | 2033 |
|
2023
Q1 | $376K | Hold |
45,152
| – | – | ﹤0.01% | 2183 |
|
2022
Q4 | $410K | Sell |
45,152
-33
| -0.1% | -$300 | ﹤0.01% | 2115 |
|
2022
Q3 | $587K | Sell |
45,185
-344
| -0.8% | -$4.47K | ﹤0.01% | 1873 |
|
2022
Q2 | $603K | Buy |
45,529
+11,030
| +32% | +$146K | ﹤0.01% | 1917 |
|
2022
Q1 | $755K | Buy |
34,499
+23,598
| +216% | +$517K | ﹤0.01% | 1919 |
|
2021
Q4 | $262 | Buy |
10,901
+218
| +2% | +$5 | ﹤0.01% | 2712 |
|
2021
Q3 | $272K | Sell |
10,683
-757
| -7% | -$19.3K | ﹤0.01% | 2751 |
|
2021
Q2 | $385K | Buy |
11,440
+3,244
| +40% | +$109K | ﹤0.01% | 2615 |
|
2021
Q1 | $318K | Buy |
8,196
+300
| +4% | +$11.6K | ﹤0.01% | 2577 |
|
2020
Q4 | $489K | Buy |
7,896
+276
| +4% | +$17.1K | ﹤0.01% | 2208 |
|
2020
Q3 | $255K | Buy |
+7,620
| New | +$255K | ﹤0.01% | 2410 |
|
2020
Q2 | – | Sell |
-10,603
| Closed | -$243K | – | 2922 |
|
2020
Q1 | $243K | Buy |
+10,603
| New | +$243K | ﹤0.01% | 2209 |
|